MmpL-3 inhibitors (StarWise Therapeutics/Marshall B. Ketchum University/Roosevelt University/Colorado State Univ/Univ Montpellier/Johns Hopkins Univ)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMmpL-3 inhibitors (StarWise Therapeutics/Marshall B. Ketchum University/Roosevelt University/Colorado State Univ/Univ Montpellier/Johns Hopkins Univ)
Drug Alias Namemycobacterial membrane protein large-3 inhibitors (StarWise Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMycobacterial membrane protein large 3 inhibitors
TargetsMycobacterial membrane protein large 3
Therapy Area/IndicationsMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStarWise Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMarshall B. Ketchum UniversityRoosevelt UniversityColorado State University +[6] 
Active IndicationsN/A
Inactive IndicationsMycobacterium Infections

Other Information

ATC CodeN/A
Related LinksN/A